F178. NEUROANATOMICAL PROFILES OF TREATMENT-RESISTANCE IN PATIENTS WITH SCHIZOPHRENIA

BACKGROUND: About 20 to 35% of patients with schizophrenia show partial or no response to standard first-line antipsychotic treatment and are thus believed to have treatment-resistant schizophrenia (TRS). Notably, the antipsychotic clozapine (CLZ) has been reported to have superior efficacy compared...

Descripción completa

Detalles Bibliográficos
Autores principales: Plitman, Eric, Iwata, Yusuke, Nakajima, Shinichiro, Chung, Jun Ku, Patel, Raihaan, Caravaggio, Fernando, Kim, Julia, De Luca, Vincenzo, Chavez, Sofia, Remington, Gary, Mallar Chakravarty, M, Gerretsen, Philip, Graff-Guerrero, Ariel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5888307/
http://dx.doi.org/10.1093/schbul/sby017.709

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5888307/
http://dx.doi.org/10.1093/schbul/sby017.709

Ejemplares similares